本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Humacyte, Inc.

1.45
-0.2300-13.69%
成交量:551.71萬
成交額:820.51萬
市值:2.25億
市盈率:-1.16
高:1.66
開:1.64
低:1.44
收:1.68
資料載入中...
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/07

SEC問詢函

Form CORRESP - Correspondence
2024/07/31

重要事件披露

Form 8-K - Current report
2024/06/13

重要事件披露

Form 8-K - Current report
2024/06/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]